Stipend and Dates

Up to $18,060 (1 payment)

Note: Cohort 1A will be filled before patients are placed in Cohort 1B Cohort 1A Cohort 1B
Admit Sep 27, 2021 Oct 03, 2021
Discharge Oct 31 Nov 06
End of Study Visit Nov 06 Nov 12

 

CLICK HERE to make an appointment for MA 4673-0004

Or call 210-225-5437 for more information

 

Study Criteria

Healthy Non-smoking Males and Females

Age 21-45

BMI 18-32 (Weight must be greater than 110 pounds)

 

Study Information

Indication: The investigational drug is being developed to treat NASH (non-alcoholic steatohepatitis)

Route of Administration: Oral

Washout from previous study: participation in another study within 30 days prior to screening or exposed to more than 4 investigational drugs within 12 months prior to the 1st dose

Acceptable Birth Control for Females (if Childbearing):  hormonal birth control, intrauterine device, double-barrier method: spermicidal gel plus condom) or abstinent from heterosexual intercourse during the study period and for 30 days after the last dose of study drug

Acceptable Birth Control for Males:  condom with spermicide or abstain from sexual intercourse from the first dose of study drug until 30 days beyond the last dose of study drug.

 

Study Reminders

  • 8 hours fasting is required for lab work (only water is allowed)
  • If taking medications, bring them to your screening appointment
  • Bring a valid, non-expired photo ID with you when you attend your screening visit.  We accept a government issued identification card such as a driver's license, state issued ID card, military ID or passport.  You will be required to show this same photo ID at all study visits
  • Arrive 30 minutes before your appointment to complete paper work.
  • You will be required to show this same photo ID at all study visits

 

Reference
MA 4673-0004
Name
Healthy Adults
Details
Not Currently Screening. Pending lab results.
Gender
Male or Female
Payment amount
Up to $18,060
Age
21 - 45
Smoking
Non-smokers